D.E. Shaw & Co’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1M | Sell |
18,940
-11,911
| -39% | -$549K | ﹤0.01% | 3377 |
|
|
2025
Q4 | $1.38M | Sell |
30,851
-17,604
| -36% | -$739K | ﹤0.01% | 3327 |
|
|
2025
Q3 | $1.95M | Sell |
48,455
-93,328
| -66% | -$3.29M | ﹤0.01% | 3002 |
|
|
2025
Q2 | $4.44M | Sell |
141,783
-10,405
| -7% | -$339K | ﹤0.01% | 2121 |
|
|
2025
Q1 | $5.11M | Buy |
152,188
+65,215
| +75% | +$2.48M | 0.01% | 1877 |
|
|
2024
Q4 | $3.41M | Sell |
86,973
-117,919
| -58% | -$4.88M | ﹤0.01% | 2296 |
|
|
2024
Q3 | $8.07M | Buy |
204,892
+43,170
| +27% | +$1.74M | 0.01% | 1577 |
|
|
2024
Q2 | $6.31M | Sell |
161,722
-36,804
| -19% | -$1.47M | 0.01% | 1681 |
|
|
2024
Q1 | $8.55M | Buy |
198,526
+114,373
| +136% | +$5.26M | 0.01% | 1477 |
|
|
2023
Q4 | $3.88M | Buy |
84,153
+43,606
| +108% | +$1.54M | 0.01% | 2113 |
|
|
2023
Q3 | $1.39M | Sell |
40,547
-58,198
| -59% | -$2.18M | ﹤0.01% | 2858 |
|
|
2023
Q2 | $3.8M | Sell |
98,745
-107,927
| -52% | -$4.29M | 0.01% | 2086 |
|
|
2023
Q1 | $7.4M | Sell |
206,672
-153,749
| -43% | -$5.68M | 0.01% | 1618 |
|
|
2022
Q4 | $14.2M | Sell |
360,421
-49,142
| -12% | -$1.79M | 0.02% | 1148 |
|
|
2022
Q3 | $14.8M | Buy |
409,563
+83,021
| +25% | +$2.98M | 0.03% | 1053 |
|
|
2022
Q2 | $9.93M | Sell |
326,542
-3,985
| -1% | -$121K | 0.02% | 1394 |
|
|
2022
Q1 | $10.1M | Sell |
330,527
-144,613
| -30% | -$4.33M | 0.01% | 1578 |
|
|
2021
Q4 | $14.8M | Buy |
475,140
+326,261
| +219% | +$9.75M | 0.02% | 1319 |
|
|
2021
Q3 | $2.27M | Sell |
148,879
-15,192
| -9% | -$264K | ﹤0.01% | 2918 |
|
|
2021
Q2 | $3.06M | Sell |
164,071
-10,924
| -6% | -$201K | ﹤0.01% | 2508 |
|
|
2021
Q1 | $3.13M | Sell |
174,995
-8,745
| -5% | -$148K | ﹤0.01% | 2204 |
|
|
2020
Q4 | $2.83M | Sell |
183,740
-8,573
| -4% | -$100K | ﹤0.01% | 2318 |
|
|
2020
Q3 | $2.13M | Sell |
192,313
-17,305
| -8% | -$204K | ﹤0.01% | 2356 |
|
|
2020
Q2 | $2.63M | Buy |
209,618
+67,110
| +47% | +$854K | ﹤0.01% | 2181 |
|
|
2020
Q1 | $1.62M | Buy |
142,508
+95,631
| +204% | +$1.36M | ﹤0.01% | 2349 |
|
|
2019
Q4 | $615K | Buy |
46,877
+15,979
| +52% | +$168K | ﹤0.01% | 3281 |
|
|
2019
Q3 | $278K | Buy |
30,898
+132
| +0.4% | +$1.25K | ﹤0.01% | 3499 |
|
|
2019
Q2 | $303K | Sell |
30,766
-24,866
| -45% | -$238K | ﹤0.01% | 3311 |
|
|
2019
Q1 | $565K | Sell |
55,632
-75,588
| -58% | -$641K | ﹤0.01% | 2932 |
|
|
2018
Q4 | $828K | Buy |
+131,220
| New | +$1.17M | ﹤0.01% | 2793 |
|
Other funds holding XENE
ACA
DCM
PCH
